Clinical Trial Update: Paclitaxel, Ifosfamide, and Carboplatin Followed By Autologous Stem Cell Transplant in Treating Patients With Germ Cell Tumors That Did Not Respond to Cisplatin [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating paclitaxel, ifosfamide, and carboplatin followed by autologous stem cell transplant in patients with cisplatin-refractory germ cell t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Central Nervous System Tumor
• Extragonadal Germ Cell Tumor
• Ovarian Germ Cell Tumor
• Teratoma
• Testicular Germ Cell Tumor

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• IFOSFAMIDE (IFOSFAMIDE)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-05-18